TFE3 and neoplasm: Surprisingly, the overexpression of ASPL-TFE3 results in increased cell populations in G2/M phases of the cell cycle, decreased Rb phosphorylation and growth suppression, which is perhaps contrary to what we might hypothesize for the molecular functions of a tumor oncogene.